PT hike an excuse to take profits in Galena


"We believe Galena (GALE -10%) is rapidly transforming itself into a multi-product oncology-focused company," says Needham analyst Chad Messer, reiterating his Buy rating and lifting the price target to $9 from $3.50.

"Since the beginning of the year the company had initiated a Phase II program for its ovarian cancer vaccine GALE-301, signed an agreement with Dr. Reddy's to fund development of lead drug NeuVax in gastric cancer, and acquired a Phase II ready specialty pharma product for essential thrombocytopenia (ET.) All of this progress comes on the heels of a successful Q4 launch of Galen'a first commercial product, Abstral."

From other sites
Comments (47)
  • shoenfield
    , contributor
    Comments (85) | Send Message
     
    So explain todays drop on no news?
    21 Jan 2014, 11:48 AM Reply Like
  • rheimerl
    , contributor
    Comments (494) | Send Message
     
    relax!...these things bounce around like ping pong balls on a daily basis
    21 Jan 2014, 11:50 AM Reply Like
  • Leroy Jackson
    , contributor
    Comments (89) | Send Message
     
    Shoenfield,

     

    I can explain it. I purchased 1000 shares last Friday.
    21 Jan 2014, 12:36 PM Reply Like
  • Rope a Dope
    , contributor
    Comments (708) | Send Message
     
    You'll learn why today. The 'smart money' saw something coming.
    22 Jan 2014, 06:29 AM Reply Like
  • Cala
    , contributor
    Comments (31) | Send Message
     
    The Street commentary is the ping pong bat wielded by AF!
    21 Jan 2014, 11:57 AM Reply Like
  • pat walsh
    , contributor
    Comments (346) | Send Message
     
    AF.IS AN A-HOLE.
    21 Jan 2014, 01:53 PM Reply Like
  • vsurapaneni
    , contributor
    Comments (10) | Send Message
     
    I agree , so is Cramer.How many times has cramer been wrong?
    21 Jan 2014, 07:50 PM Reply Like
  • emaple7140@aol,com
    , contributor
    Comments (4) | Send Message
     
    Cramer and Adam F have pulled this scheme before on some of my other stocks. I wish the SEC could shut them down or somebody would sue there pants off.
    23 Jan 2014, 11:28 AM Reply Like
  • Robert.from.Ct
    , contributor
    Comments (1011) | Send Message
     
    Who is AF? Thanks,Robert
    23 Jan 2014, 09:17 PM Reply Like
  • listech
    , contributor
    Comments (19) | Send Message
     
    It's obviously tempting for someone not in it for the long run and not interested in what the company really has to offer in Oncology, to bail out and take a short run profit when clowns like Cramer say "run"!
    This is a good longer term investment that's still very affordable so rheimerl is right ... relax!
    21 Jan 2014, 12:03 PM Reply Like
  • jeepman58
    , contributor
    Comments (225) | Send Message
     
    It looks like a gift - the opportunity to buy Jan 2016 $3 calls is $1.20 cheaper today than it was Friday. Cramer is a veteran, but he doesn't like small biotech firms - they are not appropriate for most of his audience who need more secure, traditional companies with earnings growth.

     

    For the more speculative amongst us, I see this dip as a great opportunity to buy at a discount.
    21 Jan 2014, 12:17 PM Reply Like
  • shoenfield
    , contributor
    Comments (85) | Send Message
     
    Maybe your right, but it seems like a mantra that when ever a stock takes a big hit it becomes a buying opportunity. When isn't it? speaking generally some times it's better to bail after say a 20 or 255 drop to bet on another horse rather than ride a loser all the way down.
    22 Jan 2014, 09:08 AM Reply Like
  • jeepman58
    , contributor
    Comments (225) | Send Message
     
    Yes Shoenfield, I never forget my worst buy of my 35 year investing career - JDS Uniphase at $140 in 1999. It was the leader in global fiber optics with strong buys by all the "professional" analysts, with PT of $200. "Can't miss" was the word on the street. Next time I looked it had dropped off the table, hit the floor, found the drain and slid to the bottom of the gutter. I've never forgotten my biggest loser. But you know, I learned a lot of lessons, one is to distrust analysts and their PT's - they are professionals but they are not perfect. Nor am I, but I have a lot more winners than losers.

     

    Once I'm following a company, unless fundamentals drastically change (products fail, management fails, economy tanks) I tend to monitor and if the price drops due to what seem like temporary market conditions (Cramer pans it in an interview, Squawk or The Street is not hot on it) I check my research again and if I disagree, I'll step in and buy more. Cramer is helpful, but he is a fast-talking Wall Street guy, and while I watch his show especially for his executive interviews, he has pushed some companies with a Cramer Bump that sank like a stone afterwards.

     

    I expect GALE to bounce around like all the biotechs are at this point in clinical trials. If it eventually tanks and all their exploration in bio-science proves to be dry holes, I'll get out. But for now, I see they have a solid pipeline of R&D progressing through clinicals, and I see the upside as unlimited. When it pops, it will likely pop on a press release after the market closes or before it opens. Ala Epizyme or Intercept or the other biotechs that get positive results.
    22 Jan 2014, 04:33 PM Reply Like
  • vsurapaneni
    , contributor
    Comments (10) | Send Message
     
    good response very practical, Thank you
    22 Jan 2014, 08:02 PM Reply Like
  • karmaswimswami
    , contributor
    Comments (125) | Send Message
     
    Definitely NOT a company I would be holding. Its ET drug is me-too and second-line, and its NeuVax program is the same old leukapherese and marinade with GMCSF and peptide antigen that we have heard before....so quickly people forget that investors have been dashed on the shoals of this strategy before. History repeats itself because no one listens.
    21 Jan 2014, 12:55 PM Reply Like
  • tipper 1
    , contributor
    Comments (328) | Send Message
     
    Have not heard from RS today....must be too busy taking his profit
    21 Jan 2014, 12:59 PM Reply Like
  • stockcatalystsdotcom
    , contributor
    Comments (96) | Send Message
     
    The only time i lost money is when i BOUGHT stocks Cramer said were a buy!
    21 Jan 2014, 01:03 PM Reply Like
  • tipper 1
    , contributor
    Comments (328) | Send Message
     
    Why would you ever do that??
    21 Jan 2014, 03:38 PM Reply Like
  • vsurapaneni
    , contributor
    Comments (10) | Send Message
     
    agree I ve lost money when cramer told to buy certain stocks
    21 Jan 2014, 07:50 PM Reply Like
  • piem18848
    , contributor
    Comments (111) | Send Message
     
    Picked up another 1000 shares of GALE on the drop! The less mention of AF the smaller his ego gets. For me its LONG on GALE. Short AF
    21 Jan 2014, 01:11 PM Reply Like
  • BuyToSell
    , contributor
    Comments (481) | Send Message
     
    Part of large runups are pullbacks. No stock can go up every day.

     

    Alot of traders will sell at a profit and then re-buy once the price drops ..

     

    I fully expect the momentum to come back within the next few days ... Relax, grab your favorite drink and enjoy the journey!

     

    And if you have money add shares at lower prices!
    21 Jan 2014, 01:30 PM Reply Like
  • Ali Balkan
    , contributor
    Comments (187) | Send Message
     
    Buy to sell......

     

    I agree with you 100%. That is exactly what I do, since it was $1.80. Now I'm self retired since last Monday and I will be 59 next month. Long live GALE, DRRX, ARNA, MSTX, URRE and ANTH. Long live Stock Market.........
    21 Jan 2014, 01:56 PM Reply Like
  • WilsonWagwa
    , contributor
    Comments (86) | Send Message
     
    You couldnt ask for a more professional leader than Mark Ahn. He is the reason why the stock is on its way to double digits.
    21 Jan 2014, 01:33 PM Reply Like
  • jonomatic_2000
    , contributor
    Comments (39) | Send Message
     
    GALE Bounce back and lift those price targets :)
    21 Jan 2014, 02:30 PM Reply Like
  • geo1960
    , contributor
    Comments (2) | Send Message
     
    Buy more! This is a great opportunity. There is really no negative news.
    21 Jan 2014, 02:30 PM Reply Like
  • rbflaw
    , contributor
    Comments (2) | Send Message
     
    Why would a price target increase be an excuse to take profits? Logic would dictate the opposite.
    21 Jan 2014, 02:30 PM Reply Like
  • BuyToSell
    , contributor
    Comments (481) | Send Message
     
    because they're in essence saying sell - and then buy some more (the important part) to take it higher (where we'll sell again and make even more $)
    21 Jan 2014, 02:57 PM Reply Like
  • p4000
    , contributor
    Comments (14) | Send Message
     
    Expect more and more volatility in the Future... +/- 10 % in a day can happen without a reason.
    21 Jan 2014, 02:32 PM Reply Like
  • myersno@msn.com
    , contributor
    Comment (1) | Send Message
     
    I have owned Gale at $1.96 and am NOT selling. Cramer is protecting the short sellers.
    MD Anderson is testing Neuvax and it has great potential as an ajunct therapy with
    herceptin. Breast cancer in my family so I support this company and it research.
    21 Jan 2014, 02:32 PM Reply Like
  • luthiell
    , contributor
    Comment (1) | Send Message
     
    Thanks guys! I'm new with pharma stocks and GALE is my first. Thx for positive thoughts!
    21 Jan 2014, 08:06 PM Reply Like
  • JoeMRI
    , contributor
    Comments (54) | Send Message
     
    Who cares about cramer. Really.
    21 Jan 2014, 09:35 PM Reply Like
  • yvonnie21
    , contributor
    Comments (3) | Send Message
     
    Welcome to pharm stocks luthiell, the world where you need to do your homework and have nerves of steel and patience :) Add GERN to your watch list - one of my favs!
    21 Jan 2014, 10:06 PM Reply Like
  • jeepman58
    , contributor
    Comments (225) | Send Message
     
    Thanks for the heads up on GERN too.

     

    I'm intrigued (and invested patiently) in RNN - very promising pancreas treatment, as well as Idra (another pingpong ball biotech with a promising pipeline). It's unlikely Pfizer will double in the next 3 years, but the biotechs with promising research and solid pipelines of clinical phase 1, 2 & 3 drugs can produce a number of multiple-baggers.
    22 Jan 2014, 04:42 PM Reply Like
  • shoenfield
    , contributor
    Comments (85) | Send Message
     
    I've been holding Gern for over a decade and still waiting to break even. If I had a dollar for every stock that had the cure for cancer just a phase or 2 (or 3) around the corner I'd be a rich man.
    Heck, add DVAX to your watch list as well as CYTX, MACK, CLDX, MNKD and a thousand more.
    Just lotto tickets with a longer play. Let's go Gale
    23 Jan 2014, 08:58 AM Reply Like
  • Hdrdr1999
    , contributor
    Comments (9) | Send Message
     
    Cramer, AF and crew completely missed the panel call on CHTP....
    22 Jan 2014, 01:29 AM Reply Like
  • Sugeifo
    , contributor
    Comment (1) | Send Message
     
    Sorry - I'am not a native speaker: can anyone explain what means "TP" in the headline of the News? (...PT hike an excuse to take profits in Galena
    22 Jan 2014, 06:02 AM Reply Like
  • dcfleck
    , contributor
    Comments (67) | Send Message
     
    "PT" = Price Target.

     

    Now, if someone could explain what "AF" means....
    22 Jan 2014, 03:26 PM Reply Like
  • Rope a Dope
    , contributor
    Comments (708) | Send Message
     
    Adam Feuerstein

     

    Adam is a well loved biopharm analyst.
    22 Jan 2014, 03:30 PM Reply Like
  • BuyToSell
    , contributor
    Comments (481) | Send Message
     
    Rope a Dope you forgot the </sarcasm> tag lol
    22 Jan 2014, 03:44 PM Reply Like
  • Rope a Dope
    , contributor
    Comments (708) | Send Message
     
    I figured that was a given!

     

    I'm not a fan of AF but I do read his comments if I run across any while researching a particular stock. He does have quite a bit of knowledge regarding biopharms and can offer some insight, although at times he appears jaded. I'm not one who only searches for views that align with my own regarding a stock, I want to hear why others think the opposite. I can't tell you how many times that has prevented me from entering a bad trade.
    22 Jan 2014, 03:58 PM Reply Like
  • piem18848
    , contributor
    Comments (111) | Send Message
     
    Rope! About Adams knowledge of Bio Pharms. Just where does a English major get that sort of thing?
    I don't mean to beat up on him but he really doesn't have any background to be reviewing the field that he does. So just where does he get the knowledge again?
    22 Jan 2014, 05:01 PM Reply Like
  • Rope a Dope
    , contributor
    Comments (708) | Send Message
     
    From the same place a community organizer gains enough knowledge to become president, and I have no idea where that is.

     

    He's been covering biopharms for quite some time now and you can pick up a lot of knowledge just by continuous research. I've learned a lot about biopharms in the 2 years I've been trading, enough that I know to steer clear of most of them.
    22 Jan 2014, 05:36 PM Reply Like
  • piem18848
    , contributor
    Comments (111) | Send Message
     
    Your right and I stay clear of AF! You can have him.
    22 Jan 2014, 07:12 PM Reply Like
  • shoenfield
    , contributor
    Comments (85) | Send Message
     
    I've been holding Gern for over a decade and still waiting to break even. If I had a dollar for every stock that had the cure for cancer just a phase or 2 (or 3) around the corner I'd be a rich man.
    Heck, add DVAX to your watch list as well as CYTX, MACK, CLDX, MNKD and a thousand more.
    Just lotto tickets with a longer play. Let's go Gale and hope today and next week and next month are not buying opportunities.
    24 Jan 2014, 08:34 AM Reply Like
  • listech
    , contributor
    Comments (19) | Send Message
     
    Rope!

     

    Well-loved? Come on. AF probably knows more about Biotech stocks than I do because I have a real job to go to everyday and can't spend 12 hours a day on research but, he's not well-loved! And Cramer is just a fast-talking con artist whose opinions can no longer be trusted...Sorry, very little sleep last night!
    28 Jan 2014, 11:06 AM Reply Like
  • Robert.from.Ct
    , contributor
    Comments (1011) | Send Message
     
    AF bashed GALE today at The Street.The shorts are driving the price down.I am long GALE
    12 Feb 2014, 01:01 PM Reply Like
  • listech
    , contributor
    Comments (19) | Send Message
     
    I'm struggling with making a decision on AMRN. When they hit the wall with the FDA last month, I decided to hold on to a relatively nice portfolio of AMRN that I felt would come back so instead of taking the loss and using the $ elsewhere, I held on. It looks like that may have been a mistake or at least a very long term investment.

     

    We all know the details and how this will probably work but does anyone have a feel for what AMRN may be thinking will be their next move? Is there a near-term possibility they may bail or is there any rumor of a sale to someone.

     

    I just can't seem to find any information on what may be in store. They seemed to have dropped off the face of the earth!
    28 Jan 2014, 11:17 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs